| Multiple Sclerosis |
1 |
1 |
| Immunization |
0 |
1 |
| COVID-19 Vaccine |
0 |
0.9 |
| Vaccines |
0 |
0.9 |
| Hepatitis B Virus |
0 |
0.62 |
| Child |
0 |
0.4 |
| COVID-19 |
0 |
0.37 |
| Disease-Modifying Therapy |
0 |
0.32 |
| Europe |
0 |
0.24 |
| Hepatitis A |
0 |
0.24 |
| Pregnancy |
0 |
0.17 |
| Georgia |
0 |
0.16 |
| Grant |
0 |
0.16 |
| Care and Maintenance of Vision |
0 |
0.14 |
| Progressive Multifocal Leukoencephalopathy |
0 |
0.11 |
| A-Scan Biometry |
0 |
0.08 |
| Continuing Medical Education |
0 |
0.08 |
| Disability |
0 |
0.08 |
| Face |
0 |
0.08 |
| Hospital |
0 |
0.08 |
| Immunoglobulin A (IgA) |
0 |
0.08 |
| Immunosuppressive Therapy |
0 |
0.08 |
| JC Virus |
0 |
0.08 |
| Leukoencephalopathy |
0 |
0.08 |
| Scan |
0 |
0.08 |
| Spain |
0 |
0.08 |